# A Study to Understand How the Study Medicine (PF-07976016) is Processed and Eliminated in Healthy Men

> **NCT07015918** · PHASE1 · COMPLETED · sponsor: **Pfizer** · enrollment: 8 (actual)

## Conditions studied

- Healthy Male Volunteers

## Interventions

- **DRUG:** [14C] PF-07976016
- **DRUG:** PF-07976016
- **DRUG:** [14C] PF-07976016

## Key facts

- **NCT ID:** NCT07015918
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2025-06-04
- **Primary completion:** 2025-07-16
- **Final completion:** 2025-08-14
- **Target enrollment:** 8 (ACTUAL)
- **Last updated:** 2025-09-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07015918

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07015918, "A Study to Understand How the Study Medicine (PF-07976016) is Processed and Eliminated in Healthy Men". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT07015918. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*